News from rhythm A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 08, 2015, 07:30 ET

Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis

Rhythm, a biopharmaceutical company, and Actavis plc (NYSE: ACT), a leading global pharmaceutical company, announced today the initiation of a Phase...

Mar 10, 2015, 08:24 ET

Afib Patients from the U.S., Canada, and the Caribbean Will Convene in Dallas for the Get in Rhythm, Stay in Rhythm Atrial Fibrillation Patient Conference

 The Get in Rhythm, Stay in Rhythm Atrial Fibrillation Patient Conference will bring together electrophysiologists, surgeons, and other...

Dec 11, 2014, 08:00 ET

Rhythm Appoints Fred T. Fiedorek, M.D., Chief Medical Officer

 Rhythm announced today the appointment of Fred T. Fiedorek, MD, as Chief Medical Officer. In this position, Dr. Fiedorek will oversee clinical...

Nov 17, 2014, 08:00 ET

New Survey Uncovers Critical Need to Break Down Barriers and Improve Communication and Education about the Link between Atrial Fibrillation and Devastating Impact of Stroke

Released today, a new survey of more than 1,200 physicians, patients with atrial fibrillation (AFib) and their caregivers uncovered important...

Oct 24, 2014, 08:00 ET

Rhythm Presents Positive Phase 2 Study Results for Relamorelin for Chronic Constipation

Rhythm announced today the presentation of results from a Phase 2a clinical trial assessing the safety and efficacy of relamorelin (RM-131) in 48...

Oct 22, 2014, 08:30 ET

Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin

 Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today announced that...

Jun 23, 2014, 08:00 ET

Rhythm Presents Clinical Data that RM-493 Increases Energy Expenditure in Obesity Study

 Rhythm announced today the presentation of results from a clinical trial that evaluated the effect of RM-493, the company's novel melanocortin...

May 10, 2014, 15:00 ET
The Heart Rhythm Society 2014 Annual Meeting - Opening Session in San Francisco (PRNewsFoto/Heart Rhythm Society)

Groundbreaking Medical News Presented This Week At Heart Rhythm 2014

 This week at Heart Rhythm 2014, the Heart Rhythm Society's (HRS) 35th Annual Scientific Sessions, new research was unveiled that will advance...

May 09, 2014, 15:21 ET

New Expert Consensus Statement Attempts To Close The Gap On Guidance For Implantable Cardioverter Defibrillator (ICD) Therapy By Addressing Specific Patient Populations

 The Heart Rhythm Society (HRS), American College of Cardiology (ACC) and American Heart Association (AHA) released Expert Consensus Statement...

May 07, 2014, 11:00 ET

Heart Rhythm Society Commences Annual Scientific Sessions In San Francisco Set To Explore The Crossroads Of Technology And Medicine

 Today, Heart Rhythm 2014, the Heart Rhythm Society's (HRS) 35th Annual Scientific Sessions and this year's premier conference on cardiac...

May 06, 2014, 11:02 ET

Rhythm Presents Positive GI Motility Results for Relamorelin (RM-131) in Phase 2 Chronic Constipation Study

Rhythm announced today the presentation of pharmacodynamic results from a Phase 2 clinical trial with relamorelin (RM-131) for the treatment of...

May 06, 2014, 11:00 ET

Rhythm Presents Positive Phase 2 Study Results for Ghrelin Prokinetic Relamorelin (RM-131) in Diabetic Gastroparesis

 Rhythm announced today the presentation of results from a Phase 2 clinical trial assessing the safety and efficacy of relamorelin (RM-131) in...

Feb 28, 2014, 17:53 ET

Rhythm to Present at the Cowen and Company 34th Annual Health Care Conference

 Rhythm announced today that Keith Gottesdiener, MD, CEO, will present a corporate update at the Cowen and Company 34th Annual Health Care...

Feb 04, 2014, 08:00 ET

"Listen To Your Heart" This February And Take Action To Ensure A Healthier You

 Nearly four million Americans suffer from arrhythmias each yeari. Arrhythmias or heart rhythm disorders affect the electrical system of the...

Sep 24, 2013, 08:00 ET

Rhythm Initiates Clinical Trial of RM-493 for Obesity Caused by Genetic Variant

 Rhythm announced today the initiation of the first of a series of clinical trials with RM-493, the company's novel melanocortin 4 receptor...

Sep 10, 2013, 06:30 ET

Rhythm Awarded $1.35 Million from The Michael J. Fox Foundation to Advance Clinical Development of RM-131 for Refractory Constipation in Parkinson's Disease

Rhythm announced today that The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded a $1.35 million research grant to Rhythm to...

May 20, 2013, 08:30 ET

Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.

 Rhythm announced today the presentation of results from a new epidemiology study demonstrating a higher prevalence of gastroparesis symptoms...

May 20, 2013, 08:30 ET

Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes

Rhythm announced today the results of a second Phase 1b clinical trial of RM-131, the company's novel ghrelin agonist for the treatment of diabetic...

May 08, 2013, 08:00 ET

President Bill Clinton Kicks Off Heart Rhythm 2013 In Denver

 Today, former United States President, Bill Clinton presents the keynote address at the Opening Plenary Session at Heart Rhythm 2013, the...

May 06, 2013, 08:00 ET

Heart Rhythm Society Launches HRS Consulting Services to Help Promote Streamlined Business Solutions and Optimal Patient Care

The Heart Rhythm Society (HRS) Board of Trustees today announced the launch of HRS Consulting Services, a new business entity designed to provide...